Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 12/20 | 0.48 |
| ▸ | POLB | P06746 | 8/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 10/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | LMNA | P02545 | 7/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.45 |
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 7/20 | 0.43 |
| ▸ | HTT | P42858 | 7/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nifurpirinol SCHEMBL148540 | 1.00 | KMT2A (0.48) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Nifurpirinol SCHEMBL28198718 | 0.80 | MITF (0.45) | KMT2APOLBTDP1MEN1ALDH1A1 | |
| Nifurquinazol SCHEMBL28198699 | 0.79 | KMT2A (0.44) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL28433359 | 0.75 | KMT2A (0.61) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL28433360 | 0.75 | KMT2A (0.61) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL31649237 | 0.74 | NPC1 (0.58) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Acetic Acid SCHEMBL4458658 | 0.71 | KMT2A (0.56) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Acetic Acid SCHEMBL4458652 | 0.71 | KMT2A (0.56) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Acetic Acid SCHEMBL4458660 | 0.71 | KMT2A (0.56) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL10643025 | 0.70 | KMT2A (0.55) | KMT2APOLBL3MBTL1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124192-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING RNA VIRAL INFECTIONS | MODEL MEDICINES INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260102384-A1 | USE OF PIPENDOXIFENE FOR TREATING INFECTIONS OF DNA VIRUSES | MODEL MEDICINES INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4706650-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF KIDNEY DISEASES | Universitätsmedizin Greifswald (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-12551475-B2 | Methods and compositions for treating RNA viral infections | MODEL MEDICINES, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| EP-4667008-A2 | METHODS AND COMPOSITIONS FOR TREATING RNA VIRAL INFECTIONS | Model Medicines, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250221388-A1 | SYSTEMS AND PROCESSES FOR AQUACULTURE CROP ROTATION | NESTE OYJ (FI) | 2025-07-10 | — | — | US | disclosed |
| US-20250152703-A1 | COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-05-15 | — | — | US | disclosed |
| CN-115379759-B | Method for controlling pests, pest control agent composition, and pest control agent set | 日本曹达株式会社 | 2025-03-14 | — | — | CN | disclosed |
| US-20250066712-A1 | PROCESSES AND SYSTEMS FOR CULTURING ALGAE OR REDUCING PATHOGENIC MICROBES FROM AN AQUEOUS MEDIUM, AS WELL AS CONCENTRATES AND USES RELATED THERETO | NESTE OYJ (FI) | 2025-02-27 | — | — | US | disclosed |
| US-20250025454-A1 | USE OF PIPENDOXIFENE TO TREAT SARS-COV-2 INFECTION | MODEL MEDICINES INC (US) | 2025-01-23 | — | — | US | disclosed |
| WO-2023218707-A1 | EXHAUST GAS TREATMENT SYSTEM, POWER GENERATION FACILITY COMPRISING SAME, AND EXHAUST GAS TREATMENT METHOD | 三菱重工業株式会社 | 2023-11-16 | — | — | WO | disclosed |
| US-20230346792-A1 | COMPOSITIONS AND METHODS FOR TREATING LUNG INFLAMMATION | HOTH THERAPEUTICS, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20230248712-A1 | METHODS AND COMPOSITIONS FOR TREATING RNA VIRAL INFECTIONS | MODEL MEDICINES, INC. | 2023-08-10 | — | — | US | disclosed |
| US-11672818-B2 | Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-06-13 | — | — | US | disclosed |
| EP-4157448-A1 | METHODS AND COMPOSITIONS FOR TREATING RNA VIRAL INFECTIONS | Model Medicines, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| US-11529312-B2 | Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-20 | — | — | US | disclosed |
| WO-2022159763-A1 | SARS-COV-2 THERAPEUTICS | MODEL MEDICINES, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
| WO-2017133517-A1 | PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF | 四川海思科制药有限公司 | 2017-08-10 | — | — | WO | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551475-B2 | Methods and compositions for treating RNA viral infections | SARS1, EIF2AK2, SNRPE | KMT2A 1780/4885POLB 149/4885L3MBTL1 2685/4885 |
| US-20260102384-A1 | USE OF PIPENDOXIFENE FOR TREATING INFECTIONS OF DNA VIRUSES | ESR1, VDR, POLL | KMT2A 1831/4885POLB 29/4885L3MBTL1 3666/4885 |
| US-11672818-B2 | Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto | NOS1, NOS2, NOS3 | KMT2A 4709/4885POLB 4533/4885L3MBTL1 3969/4885 |
| US-20260124192-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING RNA VIRAL INFECTIONS | SARS1, NSUN2, NSUN3 | KMT2A 1708/4885POLB 306/4885L3MBTL1 3449/4885 |
| US-20250025454-A1 | USE OF PIPENDOXIFENE TO TREAT SARS-COV-2 INFECTION | EIF2AK2, ACE2, SARS1 | KMT2A 1615/4885POLB 45/4885L3MBTL1 4271/4885 |
| US-11529312-B2 | Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use | FPR2, FPR1, PLA2G4C | KMT2A 4324/4885POLB 3111/4885L3MBTL1 2248/4885 |
| US-20230346792-A1 | COMPOSITIONS AND METHODS FOR TREATING LUNG INFLAMMATION | ACE2, TMPRSS2, VIPR1 | KMT2A 2320/4885POLB 2300/4885L3MBTL1 4238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.